Keay Nakae Stock Analyst Profile - Chardan Capital Research Coverage - Stocknear

Keay Nakae

Stock Analyst at Chardan Capital

(3.7)
# 2324
Out of 5,459 analysts
297
Total ratings
Success rate
Average return
40 Stocks
Name Action PT Current % Upside Ratings Updated
OBIO Orchestra BioMed Hld...
Maintains: Buy
20 20
2.84 604.23% 12 Aug 13, 2025
KRRO Korro Bio
Maintains: Buy
25 25
21.58 15.85% 3 Aug 13, 2025
MNPR Monopar Therapeutics
Maintains: Buy
60 60
34.81 72.36% 2 Aug 13, 2025
COYA Coya Therapeutics
Maintains: Buy
14 14
6.56 113.41% 20 Aug 13, 2025
ARWR Arrowhead Pharma
Maintains: Buy
60 60
21.79 175.36% 20 Aug 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 5
3.65 36.99% 13 Aug 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 4
2.21 81% 15 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
75 75
47.82 56.84% 18 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 12
2.12 466.04% 16 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 35
5.2 573.08% 13 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
325 400
454.18 -11.93% 14 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
50 38
13.64 178.59% 13 Jul 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 5
0.81 517.28% 5 Jun 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
2 6
18.88 -68.22% 10 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 20
3.55 463.38% 14 Apr 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 6
1.86 222.58% 7 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
3 3
2.19 14.16% 6 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 8
n/a n/a 10 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 6
n/a n/a 6 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 5
n/a n/a 2 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Feb 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
9
n/a n/a 6 Aug 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
8 6
16.12 -62.78% 7 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
8
n/a n/a 5 Mar 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
50
n/a n/a 4 Nov 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 20
0.54 3603.7% 4 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
65 55
8.59 540.28% 10 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
175 125
n/a n/a 4 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Oct 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 10
5.88 70.07% 5 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jun 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 2
n/a n/a 4 Apr 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28 39
n/a n/a 4 Dec 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
100 88
11.16 684.05% 2 Sep 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1 13
1.04 1150% 3 Feb 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Nov 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
155 40
3.2 1150% 2 Jun 30, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On: Buy
3 0
n/a n/a 3 May 5, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
65 70
n/a n/a 2 Mar 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22500
n/a n/a 1 Jun 2, 2017